Market
Primary focus of discourse on Pfizer documents by mid-2025?
2
Resolution / Starting Odds
Vaccine Safety • 25%
Data Transparency • 25%
FDA's Handling • 25%
Effectiveness of Vaccines • 25%
Analysis of public discourse through media publications and social media trends
Story
FDA Ordered to Release Over a Million Pages of Pfizer's Vaccine Trial Documents in Transparency Win
Dec 7, 2024, 01:39 AM
A U.S. federal judge has ordered the Food and Drug Administration (FDA) to release an additional million pages of documents related to Pfizer's COVID-19 vaccine trials. This decision follows a lawsuit filed by Aaron Siri, who has been advocating for transparency in the vaccine approval process. The FDA had previously attempted to keep these documents hidden from the public for 75 years, citing the need for time to process the extensive data. The court's ruling marks a significant victory for transparency, as it compels the FDA to disclose information underpinning its authorization of the vaccines, despite the agency's efforts to end the public records lawsuit.
View original story
Similar markets
Regulatory approval process • 25%
Vaccine efficacy data • 25%
Adverse side effects • 25%
Trial participant demographics • 25%
Legal challenges against FDA • 25%
Increased transparency and trust • 25%
No significant impact • 25%
Policy changes in vaccine approval • 25%
FDA • 25%
WHO • 25%
CDC • 25%
Pfizer • 25%
Pfizer • 25%
FDA • 25%
Public Health Organizations • 25%
No major impact on any organization • 25%
Decreased trust in vaccines • 25%
Increased demand for transparency • 25%
Indifference • 25%
Increased trust in vaccines • 25%
Increase trust • 25%
Mixed impact • 25%
No significant change • 25%
Decrease trust • 25%
Increased transparency • 25%
No major changes • 25%
Enhanced oversight • 25%
Funding restrictions • 25%